Amphastar Pharmaceuticals (AMPH) Interest & Investment Income (2013 - 2026)

Amphastar Pharmaceuticals' Interest & Investment Income history runs 14 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 14.89% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $9.0 million (down 11.38% YoY), while the FY2025 annual figure was $8.7 million, down 18.22% from the prior year.
• Interest & Investment Income was $2.4 million for Q1 2026 at Amphastar Pharmaceuticals, down from $2.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.3 million in Q2 2024 to a low of $181000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $1.7 million across 5 years, with a median of $2.1 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 410.5% in 2023, then plunged 42.43% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $580000.0 in 2022, then soared by 297.07% to $2.3 million in 2023, then retreated by 0.48% to $2.3 million in 2024, then advanced by 5.72% to $2.4 million in 2025, then decreased by 0.95% to $2.4 million in 2026.
• The last three Interest & Investment Income figures came in at $2.4 million (Q1 2026), $2.4 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.